Estelle is Senior Vice President at SixPeaks Bio, leading the nonclinical and translational development of the company’s portfolio.  A seasoned drug developer, she combines scientific innovation with regulatory know-how to bring assets into the clinic, as proven by her track record of successful IND/CTA filings. Previously, she served as CDO at 3T Biosciences and held leading roles in Research and Early Development at Roche and Novartis. Estelle holds a PhD in Microbiology from the University Louis Pasteur in Strasbourg, France.